M&A TRANSACTION · 2023
AngioDynamics Dialysis Product Portfolio and BioSentry Product acquired by Merit Medical Systems, Inc.
$100.0M· 3.10x revenue
Target
AngioDynamics Dialysis Product Portfolio and BioSentry Product
Acquirer
Merit Medical Systems, Inc.
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$32.0M
EBITDA
—
Deal Value
$100.0M
EV/EBITDA
—
Context
This $100.0M acquisition of AngioDynamics Dialysis Product Portfolio and BioSentry Product by Merit Medical Systems, Inc. sits in the medical devices sub-vertical. Merit Medical Systems, Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.
Source
Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical devices
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the AngioDynamics Dialysis Product Portfolio and BioSentry Product acquisition.